A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study

Background: This study was a multicenter, randomized, double-blinded, placebo-controlled phase III clinical trial to investigate the efficacy and safety of an olmesartan/amlodipine single pill plus rosuvastatin combination treatment for patients with concomitant hypertension and dyslipidemia. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Sang-Ho, Kang, Seok Min, Yoo, Byung Su, Lee, Young Soo, Youn, Ho Joong, Min, Kyungwan, Yu, Jae Myung, Yoon, Hyun Ju, Kim, Woo Shik, Kim, Gee Hee, Park, Jae Hyoung, Kim, Seok Yeon, Kim, Cheol Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779537/
https://www.ncbi.nlm.nih.gov/pubmed/35054044
http://dx.doi.org/10.3390/jcm11020350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779537/
https://www.ncbi.nlm.nih.gov/pubmed/35054044
http://dx.doi.org/10.3390/jcm11020350

Ejemplares similares